Ovid Therapeutics Inc. – Trademark Portfolio
Entity Type: 03
Ovid Therapeutics Inc. holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include OVID, CGI-I-AS, CGI-S-AS, BOLDMEDICINE, and OVID THERAPEUTICS. The owner is based in New York, NY.
Suite 15044
1460 Broadway
New York, NY 10036
Showing of trademarks Trademarks
Trademark Classifications
Ovid Therapeutics Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Ovid Therapeutics Inc. have?
Ovid Therapeutics Inc. has 18 U.S. trademarks filed with the USPTO. Of these, 7 registered, 9 abandoned, 2 cancelled.
What trademark classes does Ovid Therapeutics Inc. file in?
Ovid Therapeutics Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Ovid Therapeutics Inc.'s most well-known trademarks?
Ovid Therapeutics Inc.'s registered trademark portfolio includes well-known marks such as OVID, CGI-I-AS, CGI-S-AS, BOLDMEDICINE, and OVID THERAPEUTICS. These are among 7 currently registered trademarks in the portfolio.
What is Ovid Therapeutics Inc.'s trademark registration success rate?
Ovid Therapeutics Inc. has a 39% trademark registration rate, with 7 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.